Los Angeles, United States
M Ventures is a uniquely positioned and constructed early-stage venture firm. We invest not only our capital but also our time, relationships, and expertise into technology companies that use software and the internet to create innovative consumer or enterprise products and solutions. Our team brings unique experiences from differentiated fields of media, entertainment, politics, finance and technology as both operators and investors to find, invest in, and grow the leading companies of the future.
36
Total Investments
18
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
SaaS
Funding Stage
Seed
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About M Ventures
Recent Investments (36)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Apr 2026 | |
| Series E | •••••• | Jan 2026 | |
| Grant | •••••• | Nov 2025 | |
| Series C | •••••• | Apr 2025 | |
| Series B | •••••• | Jan 2025 | |
•••• ••••
|
Late Vc | •••••• | Sep 2024 |
|
•••• ••••
|
Late Vc | •••••• | Apr 2024 |
|
•••• ••••
|
Series C | •••••• | Mar 2024 |
|
•••• ••••
|
Series B | •••••• | Jun 2023 |
|
•••• ••••
|
Series A | •••••• | Mar 2023 |
Latest News
Kanser tedavisine yönelik ilaçlar geliştiren Storm Therapeutics, 56 milyon dolar yatırım aldı
Webrazzi · Apr 17, 2026
STORM Therapeutics raises €47.5 million Series C to harness the power of RNA modification to treat cancer
Eu-startups · Apr 16, 2026
Cambridge biotech STORM Therapeutics raises $56M
Thenextweb · Apr 16, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
